
New Standards in Diffuse Lower-Grade Gliomas: Integrative Management From Surgery to Survivorship
10.06.2025
0:00
25:32
Which patients with IDH-mutant glioma should receive an isocitrate dehydrogenase (IDH) inhibitor? A top neurosurgeon weighs in.
Credit available for this activity expires: 6/9/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002598?ecd=bdc_podcast_libsyn_mscpedu
Więcej odcinków z kanału "Keeping Current CME"
Nie przegap odcinka z kanału “Keeping Current CME”! Subskrybuj bezpłatnie w aplikacji GetPodcast.